News

The Food and Drug Administration (FDA) has accepted for review the supplemental Biologics Application (sBLA) for fremanezumab-vfrm to include the ...
Artificial intelligence (AI) can accurately suggest appropriate adjuvant treatment for patients with early breast cancer, according to research published in JCO Clinical Cancer Informatics.
HealthDay News — The US Senate has confirmed the appointment of Mehmet Oz, MD, to head the Centers for Medicare & Medicaid Services (CMS), according to a report from The New York Times.
Based on these findings, the USPSTF concludes that primary care behavioral counseling interventions to support breastfeeding have a moderate net benefit, with moderate certainty. Interventions or ...
Semaglutide use associated with increased risk for NAION at the 2-, 3-, and 4-year time point from the index date.
In a webinar hosted by ANAC, speakers discuss how providers can make transgender patients feel more trusting and accepted in the health care setting.
Erzofri is an atypical antipsychotic that is administered once a month as an intramuscular injection by a health care professional.
About 74% of respondents were unaware of FDA-approved treatments; 56% said these options had not been discussed by clinician.
Researchers sought to compare the effect of abelacimab vs rivaroxaban on risk for bleeding in patients with atrial fibrillation.
HealthDay News — The Geriatric Nutritional Risk Index (GNRI) is a reliable predictive marker for overactive bladder (OAB) in the elderly, according to a study published in Frontiers in Nutrition.
Elevated circulating tumor DNA (ctDNA) fraction and tumor suppressor gene loss are associated with worse prognosis in patients with prostate cancer liver metastases (PCLM), accord ...
Several biomarker tests have been available for over a decade, with extensive research backing their effectiveness. Yet, many urologists remain unaware of their full potential to streamline practice ...